Demographic characteristics and clinical manifestations of systemic sclerosis in Benghazi, Libya

被引:2
|
作者
Elbraky, Fathi M. [1 ]
Amailaf, Imhamed A. [1 ]
Alsaeiti, Khaled D. [2 ]
机构
[1] Benghazi Univ, Fac Med, Dept Internal Med, Benghazi, Libya
[2] Aljamhorya Hosp, Dept Internal Med, Benghazi, Libya
来源
IBNOSINA JOURNAL OF MEDICINE AND BIOMEDICAL SCIENCES | 2020年 / 12卷 / 02期
关键词
Benghazi; diffuse; epidemiology; Libya; localized; rheumatology; systemic sclerosis; CLASSIFICATION CRITERIA; SCLERODERMA; EPIDEMIOLOGY; ASSOCIATION; PROFILE; RISK;
D O I
10.4103/ijmbs.ijmbs_36_20
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Systemic sclerosis (SSc) is a rare, heterogeneous autoimmune disease characterized by skin fibrosis, vasculopathy, and internal organ involvement. This study aims to determine the frequency of clinical manifestations of SSc among Libyan patients in Benghazi. Patients and Methods: Thirty patients (28 females) attended the Rheumatology Clinic at Benghazi Medical Center between January 2016 and December 2019. They were diagnosed to have SSc according to American College of Rheumatology/European League Against Rheumatism 2013 revised classification criteria and were classified into diffuse cutaneous systemic sclerosis (dcSSc) and localized systemic sclerosis (lcSSc) disease subsets. Results: We reviewed the data of the 30 patients, including 28 (93.3%) females and 2 (6.7%) males (female: male ratio 14:1); the mean age at diagnosis was 40.5 +/- 21.5 years (17-62 years). Twenty-four (80%) patients were diagnosed as dcSSc, whereas 6 (20%) were diagnosed as lcSSc. On diagnosis, patients with dcSSc were comparatively younger than those with lcSSc. The frequency of musculoskeletal manifestations and organ involvement was more frequent among patients with dcSSc (P = 0.001). All the thirty patients had rheumatoid factor and anti-nuclear antibody positivity. Anti-Scl-70 was only positive in the dcSSC subset in all patients of dcSSc only, whereas anti-centromere Ab was positive in all patients of lcSSc only. Conclusions: This is the first study to assess the clinical manifestations of SSc in the Libyan population. Our disease cohort showed similarity to what was published in other cohorts with regard to the age at the time of diagnosis, gender, and autoimmune profile.
引用
收藏
页码:118 / 122
页数:5
相关论文
共 50 条
  • [21] Demographic and Clinical Factors Associated with Physician Service Use in Systemic Sclerosis
    Bernatsky, Sasha
    Panopolis, Pantelis
    Hudson, Marie
    Pope, Janet
    Leclercq, Sharon
    Robinson, David
    Jones, Niall
    Markland, Janet
    Abu-Hakima, Maysan
    Mathieu, Jean-Pierre
    Docherty, Peter
    Khalidi, Nader
    Sutton, Evelyn
    Baron, Murray
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (01) : 96 - 98
  • [22] Biomarkers reflecting the pathogenesis, clinical manifestations, and guide therapeutic approach in systemic sclerosis: a narrative review
    Bazso, Anna
    Dsci, Peter Szodoray Med
    Shoenfeld, Yehuda
    Dsci, Emese Kiss Med
    CLINICAL RHEUMATOLOGY, 2024, 43 (10) : 3055 - 3072
  • [23] Esophagus involvement in systemic sclerosis: ultrasound parameters and association with clinical manifestations
    Ma, Li
    Zhu, Qingli
    Zhang, Yan
    Li, Jianchu
    Jiang, Yuxin
    Xu, Dong
    Zeng, Xiaofeng
    Hou, Yong
    Liu, He
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [24] Relationship Between Disease Characteristics and Orofacial Manifestations in Systemic Sclerosis: Canadian Systemic Sclerosis Oral Health Study III
    Baron, Murray
    Hudson, Marie
    Tatibouet, Solene
    Steele, Russell
    Lo, Ernest
    Gravel, Sabrina
    Gyger, Genevieve
    El Sayegh, Tarek
    Pope, Janet
    Fontaine, Audrey
    Masetto, Ariel
    Matthews, Debora
    Sutton, Evelyn
    Thie, Norman
    Jones, Niall
    Copete, Maria
    Kolbinson, Dean
    Markland, Janet
    Nogueira, Getulio
    Robinson, David
    Fritzler, Marvin
    Gornitsky, Mervyn
    ARTHRITIS CARE & RESEARCH, 2015, 67 (05) : 681 - 690
  • [25] Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies
    Motegi, Sei-ichiro
    Toki, Sayaka
    Yamada, Kazuya
    Uchiyama, Akihiko
    Ishikawa, Osamu
    JOURNAL OF DERMATOLOGY, 2015, 42 (02) : 189 - 192
  • [26] Demographic and Clinical Characteristics of Familial and Sporadic Multiple Sclerosis Patients
    Mokhtari, Shahrzad
    Houshi, Shakiba
    Mirmosayyeb, Omid
    Barzegar, Mahdi
    Afshari-Safavi, Alireza
    Ghasemi, Majid
    Shaygannejad, Vahid
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2023, 14 (01) : 86
  • [27] Progressive, systemic sclerosis: Clinical manifestations and anesthetic considerations
    Roberts, JG
    Sabar, R
    Gianoli, JA
    Kaye, AD
    JOURNAL OF CLINICAL ANESTHESIA, 2002, 14 (06) : 474 - 477
  • [28] The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink
    Royle, Jeremy G.
    Lanyon, Peter C.
    Grainge, Matthew J.
    Abhishek, Abhishek
    Pearce, Fiona A.
    CLINICAL RHEUMATOLOGY, 2018, 37 (08) : 2103 - 2111
  • [29] Clinicopathological characteristics of lung cancer in patients with systemic sclerosis
    Chen, Minjiang
    Liu, Xiaoyan
    Xu, Yan
    Zhou, Qing
    Shi, Yuequan
    Zhang, Dongming
    Liang, Hongge
    Zhao, Jing
    Zhong, Wei
    Wang, Mengzhao
    CLINICAL RESPIRATORY JOURNAL, 2020, 14 (12) : 1131 - 1136
  • [30] Colonic and Anorectal Manifestations of Systemic Sclerosis
    Sattar B.
    Chokshi R.V.
    Current Gastroenterology Reports, 2019, 21 (7)